VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 732 filers reported holding VANECK VECTORS ETF TR in Q1 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,958,647 | -14.0% | 72,785 | -3.8% | 0.40% | -5.6% |
Q2 2023 | $2,277,159 | -8.5% | 75,628 | -1.7% | 0.43% | -15.0% |
Q1 2023 | $2,489,947 | +124397.4% | 76,969 | +93764.6% | 0.50% | – |
Q2 2022 | $2,000 | 0.0% | 82 | +54.7% | 0.00% | – |
Q1 2022 | $2,000 | +100.0% | 53 | +29.3% | 0.00% | – |
Q4 2021 | $1,000 | -66.7% | 41 | -58.2% | 0.00% | -100.0% |
Q3 2021 | $3,000 | -50.0% | 98 | -46.4% | 0.00% | 0.0% |
Q2 2021 | $6,000 | 0.0% | 183 | +5.8% | 0.00% | 0.0% |
Q1 2021 | $6,000 | -99.7% | 173 | -99.7% | 0.00% | -99.8% |
Q4 2020 | $2,393,000 | -13.2% | 66,438 | -5.6% | 0.60% | -33.0% |
Q3 2020 | $2,756,000 | +137700.0% | 70,384 | +70284.0% | 0.90% | +89500.0% |
Q4 2017 | $2,000 | -50.0% | 100 | -41.2% | 0.00% | -75.0% |
Q3 2017 | $4,000 | -20.0% | 170 | -22.7% | 0.00% | -20.0% |
Q2 2017 | $5,000 | 0.0% | 220 | 0.0% | 0.01% | 0.0% |
Q1 2017 | $5,000 | 0.0% | 220 | 0.0% | 0.01% | -28.6% |
Q4 2016 | $5,000 | – | 220 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |